Key result
Auxiliary middle cardiac vein shock reduces defibrillation threshold by ~23% over conventional shock alone.
Why the study?
Defibrillation in the middle cardiac vein and low amplitude auxiliary shocks have been shown to reduce ventricular defibrillation thresholds, but the impact of an auxiliary shock from a transvenously placed MCV lead system was not investigated.
Does an auxiliary shock delivered from a transvenously placed middle cardiac vein lead system reduce ventricular defibrillation thresholds in a porcine model?
RCT (n=8)
Randomized
Does an auxiliary shock delivered from a transvenously placed middle cardiac vein lead system reduce ventricular defibrillation thresholds in a porcine model?
Delivering an auxiliary shock from a transvenous lead system in the middle cardiac vein reduces the defibrillation threshold by 23% compared to a conventional RV-to-Can shock alone in a porcine model.
Answers are grounded in this paper and cite their sources.
Transvenous MCV auxiliary shock reduced DFT 23% in this model; leaves open translation to human ICD outcomes.
Defibrillation in the middle cardiac vein (MCV) has been shown to reduce ventricular defibrillation thresholds (DFTs). Low amplitude auxiliary shock (AS) from an electrode sutured to the left ventricle at thoracotomy have also been shown to reduce DFT if delivered immediately prior to a biphasic shock (between the ventricular RV and superior vena caval (SVC) electrodes). This study investigates the impact on DFT of an AS shock from a transvenously placed MCV lead system. A standard defibrillation electrode was positioned in the RV in eight anesthetized pigs (35-43 kg). A 50 x 1.8-mm electrode was inserted in the MCV through an 8 Fr angioplasty guide catheter. A 150-V (leading edge) monophasic AS was delivered (95 microF capacitor) from the MCV-->Can with three different pulse widths (3, 5, 7 ms). A primary biphasic shock (PS) (95 microF capacitor, phase 1: 44% tilt, 1.6-ms extension and phase 2: 2.5-ms fixed duration) was delivered from the RV-->Can +/- AS. The four configurations were randomized and DFTs (PS + AS) assessed using a modified binary search. Ventricular fibrillation (VF) was induced with 60 Hz AC followed 10 seconds later by the test shock. The DFTs were compared using repeated measures analysis of variance (ANOVA). All configurations incorporating AS produced significant (P < 0.05) reduction in the DFT compared to no AS (13.8 +/- 7.4 J). There was no difference in the efficacy of differing pulse widths (P > 0.05); 3 ms (11.0 +/- 5.4 J), 5 ms (11.5 +/- 6.0), and 7 ms (10.6 +/- 5.3 J). In conclusion, delivering an AS from a transvenous lead system deployed in the MCV reduces the DFT by 23% compared to a conventional RV-->Can shock alone.
No takes yet. Share an insight, caveat, or question.
ROBERTS et al. (2000) conducted an RCT in Ventricular fibrillation (n=8). Auxiliary shock from a transvenously placed middle cardiac vein lead system vs. No auxiliary shock (conventional RV to Can shock alone) was evaluated on Defibrillation threshold (DFT) (23% reduction, p=< 0.05). Delivering an auxiliary shock from a transvenous lead system deployed in the middle cardiac vein reduced the defibrillation threshold by 23% compared to a conventional shock alone.
Synapse has enriched 10 related papers. Consider them for comparative context: